Christine Guillard Maure
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christine Guillard Maure has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
Varalakshmi Elango
P95 Pharmacovigilance and Epidemiology, Leuven, Belgium
3 shared publicationsBarbee Whitaker
Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA
2 shared publicationsHugo Devlieger
Universitair Ziekenhuis, Leuven, Belgium
2 shared publicationsHui-Lee Wong
Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA
2 shared publicationsMargarita Riera-Montes
P95 Pharmacovigilance and Epidemiology, Leuven, Belgium
2 shared publicationsMathews Mathai
Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK
2 shared publications
Latest Publications
- Open Access
- 17 June 2022
- Published by Elsevier in eClinicalMedicine
- Vol. 50, 101506
Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy
- 17 June 2022
- Published by Elsevier in eClinicalMedicine
- Vol. 50, 101506
Open AccessEstimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy
- Open Access
- 9 April 2022
- Published by Elsevier in Vaccine: X
- Vol. 11, 100160
Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project
- 9 April 2022
- Published by Elsevier in Vaccine: X
- Vol. 11, 100160
Open AccessOperational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project
- Open Access
- 22 March 2018
- Published by MDPI AG in Methods and Protocols
- Vol. 1 (2) , 11
Intussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India
India has recently introduced a rotavirus vaccine under a universal immunization program. There is limited information on intussusception, an adverse event, following immunization in children from India. We are conducting sentinel surveillance for intussusception in children aged under two years at 19 hospitals. The sentinel sites’ selection followed a multistage process. The surveillance combines retrospective surveillance for 69 months and prospective surveillance for 18 months. The suspected intussusception cases shall be reviewed for capturing confirmed cases and detailed data collection and classification according to Brighton Collaboration criteria. Data shall be analysed to describe epidemiology, trends, regional and seasonal variations, clinical profiles, management modalities, and outcomes of intussusception. The combination of prospective and retrospective surveillance shall be informative about the trend of intussusception over the last seven years in India. At four sites where rotavirus vaccines have been introduced, the change in intussusception trends shall be documented. The potential association with rotavirus vaccines and other vaccines shall be assessed using case-control and self-controlled case series methodology. Results are forthcoming. The results shall support the national vaccine safety surveillance effort by providing baseline estimates of intussusception for continued monitoring. The surveillance protocol and site selection processes shall inform similar vaccine-safety surveillance in India and other developing countries.
- 22 March 2018
- Published by MDPI AG in Methods and Protocols
- Vol. 1 (2) , 11
Open AccessIntussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India
India has recently introduced a rotavirus vaccine under a universal immunization program. There is limited information on intussusception, an adverse event, following immunization in children from India. We are conducting sentinel surveillance for intussusception in children aged under two years at 19 hospitals. The sentinel sites’ selection followed a multistage process. The surveillance combines retrospective surveillance for 69 months and prospective surveillance for 18 months. The suspected intussusception cases shall be reviewed for capturing confirmed cases and detailed data collection and classification according to Brighton Collaboration criteria. Data shall be analysed to describe epidemiology, trends, regional and seasonal variations, clinical profiles, management modalities, and outcomes of intussusception. The combination of prospective and retrospective surveillance shall be informative about the trend of intussusception over the last seven years in India. At four sites where rotavirus vaccines have been introduced, the change in intussusception trends shall be documented. The potential association with rotavirus vaccines and other vaccines shall be assessed using case-control and self-controlled case series methodology. Results are forthcoming. The results shall support the national vaccine safety surveillance effort by providing baseline estimates of intussusception for continued monitoring. The surveillance protocol and site selection processes shall inform similar vaccine-safety surveillance in India and other developing countries.
- Open Access
- 31 March 2017
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 15 (1) , 28
Development of the Good Health Research Practice course: ensuring quality across all health research in humans
Quality and ethics need to be embedded into all areas of research with human participants. Good Clinical Practice (GCP) guidelines are international ethical and scientific quality standards for designing, conducting, recording and reporting trials involving human participants. Compliance with GCP is expected to provide public assurance that the rights, safety and wellbeing of participants are protected and that the clinical research data are credible. However, whilst GCP guidelines, particularly their principles, are recommended across all research types, it is difficult for non-clinical trial research to fit in with the exacting requirements of GCP. There is therefore a need for guidance that allows health researchers to adhere to the principles of GCP, which will improve the quality and ethical conduct of all research involving human participants. These concerns have led to the development of the Good Health Research Practice (GHRP) course. Its goal is to ensure that research is conducted to the highest possible standards, similar to the conduct of trials to GCP. The GHRP course provides training and guidance to ensure quality and ethical conduct across all health-related research. The GHRP course has been run so far on eight occasions. Feedback from delegates has been overwhelmingly positive, with most delegates stating that the course was useful in developing their research protocols and documents. Whilst most training in research starts with a guideline, GHRP has started with a course and the experience gained over running the courses will be used to write a standardised guideline for the conduct of health-related research outside the realm of clinical trials, so that researchers, funders and ethics committees do not try to fit non-trials into clinical trials standards.
- 31 March 2017
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 15 (1) , 28
Open AccessDevelopment of the Good Health Research Practice course: ensuring quality across all health research in humans
Quality and ethics need to be embedded into all areas of research with human participants. Good Clinical Practice (GCP) guidelines are international ethical and scientific quality standards for designing, conducting, recording and reporting trials involving human participants. Compliance with GCP is expected to provide public assurance that the rights, safety and wellbeing of participants are protected and that the clinical research data are credible. However, whilst GCP guidelines, particularly their principles, are recommended across all research types, it is difficult for non-clinical trial research to fit in with the exacting requirements of GCP. There is therefore a need for guidance that allows health researchers to adhere to the principles of GCP, which will improve the quality and ethical conduct of all research involving human participants. These concerns have led to the development of the Good Health Research Practice (GHRP) course. Its goal is to ensure that research is conducted to the highest possible standards, similar to the conduct of trials to GCP. The GHRP course provides training and guidance to ensure quality and ethical conduct across all health-related research. The GHRP course has been run so far on eight occasions. Feedback from delegates has been overwhelmingly positive, with most delegates stating that the course was useful in developing their research protocols and documents. Whilst most training in research starts with a guideline, GHRP has started with a course and the experience gained over running the courses will be used to write a standardised guideline for the conduct of health-related research outside the realm of clinical trials, so that researchers, funders and ethics committees do not try to fit non-trials into clinical trials standards.
- Open Access
- 31 July 2014
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 92 (9) , 695-696
The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
- 31 July 2014
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 92 (9) , 695-696
Open AccessThe Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level